School of Pharmacy Directory

Search for People by Name, Department, or Organizational Unit
General School of Pharmacy Contact Info

Maria Agapova Graduate Student

Photo of Maria Agapova
Graduate StudentDepartment of Pharmacy

Admission: Fall 2010

  • BS, Randolph College, Virginia
  • MSc, Bocconi University, Italy

Research Interests:
Disease progression modeling, cost-effectiveness analysis and economic evaluation of health interventions in transitioning countries.

Javier Aguilera Research Associate

No Photo Available

Theresa Aliwarga Graduate Student

No Photo Available
Graduate StudentDepartment of Medicinal Chemistry

Totah Lab

Rachel Allen Clinical Assistant Professor

Photo of Rachel Allen
Clinical Assistant ProfessorDepartment of PharmacyAddress T490 Phone: 206-616-5182


Clinical Assistant Professor, Department of Pharmacy,
Office of Professional Pharmacy Education, BPLC Director


  • PharmD, University of Washington

Research Interests

  • Community practice
  • Clinical community pharmacy services

Gail Anderson Professor

Photo of Gail Anderson
ProfessorDepartment of PharmacyAddress H361A Box 357630 1959 NE Pacific St Seattle WA 98195.7630 Phone: 206.685.1864 Work Fax: 206.543.3835Website: Pub Med


Professor, Department of Pharmacy; Adjunct Professor, Department of Pharmaceutics, Department of Neurological Surgery, UW Medicine


  • PhD in Pharmaceutics, University of Washington
  • Master of Science in Pharmacy Practice, University of Washington
  • Bachelor of Science in Pharmacy, University of Washington

Research Interests

  • Clinical pharmacokinetics
  • Epilepsy and neurotrauma

Courses Taught

  • Pharm 561 and 562: Pharmacotherapeutics
  • Pharm 549: Drug therapy for the elderly
  • Pharm 533: Pharmacokinetics
  • Pceut 532: Clinical Pharmacokinetics
  • Pceut 533: Biopharmaceutics and drug delivery
  • Med Chem 525: Alternative and Complementary Medicine (online)


Gail D. Anderson, PhD, obtained her academic education from the University of Washington where she obtained a Bachelor of Science in Pharmacy, Master of Science in Pharmacy Practice and PhD in Pharmaceutics. She completed a fellowship in Clinical Pharmacokinetics at the State University of New York at Buffalo and an NIH training fellowship at the Regional Epilepsy center at UW Medical Center. Her research interests include treatment issues in traumatic brain injury and epilepsy, pharmacokinetics and drug interactions.

Dr. Anderson has been an investigator on numerous federal and industry funded research grants and is author of over 100 peer-reviewed publications and chapters. She teaches clinical pharmacokinetics and antiepileptic drugs to students in a variety of health professional programs, including pharmacy, nursing and physician assistants. Dr. Anderson also offers a self-paced online course on natural products. In 2005, she won the UW Gibaldi Excellence in Teaching Award and in 2011 the Distinguished Alumna for Excellence in Pharmaceutical Science and Research Award from the UW School of Pharmacy. Dr. Anderson is active in various pharmacy and epilepsy professional organizations and has been on the professional advisory board of the Epilepsy Foundation Northwest since 1993. She serves on the editorial board of the journal Clinical Pharmacokinetics and as a grant reviewer for several National Institutes of Health review committees including, NCCAM, NINDS and NICHD.

Peer Reviewed Publications

  • Anderson GD, Hakimian S. Pharmacokinetics of antiepilectic drugs in patients with hepatic and renal impairment. Clin Pharmacokinet 2014; 53:29-39.
  • Vonder Haar C, Anderson GD, Elmore BE, Moore LH, Bunton AM, Kantor ED, Farin FM, Bammler TK, Macdonald JW, Hoane MR. Comparison of the Effect of Minocycline and Simvastatin on Functional Recovery and Gene Expression in a Rat Traumatic Brain Injury Model. J Neurotrauma. 2013 Dec 5; ePUB ahead of print.
  • Anderson GD, Peterson TC, Vonder Haar C, Farin FM, Bammler TK, Kantor ED, MacDonald JW, Hoane MR. Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model. Front Neurosci. 2013 Oct 17; 4:129. doi: 10.3389/fphar.2013.00129.
  • Ruddy J, Emerson J, Moss R, Genatossio A, McNamara S, Burns JL, Anderson GD, Rosenfeld M. Sputum tobramycin concentrations in cystic fibrosis patients with repeated administration of inhaled tobramycin. J Aerosol Med Pulm Drug Deliv. 2013 Apr; 26(2):69-75.
  • Anderson GD, Peterson TC, Farin FM, Bammler TK, Beyer RP, Kantor ED, Hoane MR. The effect of nicotinamide on gene expression in a traumatic brain injury model. Front Neurosci. 2013 Feb 26; 7:21.
  • Peterson TC, Anderson GD, Kantor ED, Hoane MR. A comparison of the effects of nicotinamide and progesterone on functional recovery of cognitive behavior following cortical contusion injury in the rat. J Neurotrauma. 2012 Dec 10; 29(18):2823-30.
  • Jimenez N, Anderson GD, Shen DD, Nielsen SS, Farin FM, Seidel K, Lynn AM. Is ethnicity associated with morphine’s side effects in children? Morphine pharmacokinetics, analgesic response, and side effects in children having tonsillectomy. Paediatr Anaesth. 2012 Jul; 22(7):669-75.
  • Anderson GD, Saneto RP. Current Oral and Non-oral Routes and Antiepileptic Drug Delivery. Adv Drug Deliv Rev. 2012 Jul; 64(10):911-8.
  • Vonder Haar C, Anderson GD, Hoane MR. Continuous nicotinamide administration improves behavioral recovery and reduces lesion size following bilateral frontal controlled cortical impact injury. Behav Brain Res. 2011 Oct 31; 224(2):311-7.
  • Anderson GD, Farin FM, Bammler TK, Beyer RP Swan A, Wilkerson HW, Kantor ED, Hoane MR. The effect of progesterone dosing on gene expression following traumatic brain injury. J Neurotrauma. 2011 Sep; 28(9):1827-43.
  • Lynn AM, Bradford H, Kantor ED, Andrew M, Vicini P, Anderson GD. Ketorolac tromethamine: stereo-specific pharmacokinetics and single-dose use in postoperative infants aged 2-6 months. Paediatr Anaesth. 2011 Mar; 21(3):325-34.

Sophie Argon Research Scientist

No Photo Available
Research ScientistDepartment of Pharmaceutics

Samuel Arnold Graduate Student

No Photo Available
Graduate StudentPharmaceutics

William Atkins Professor

Photo of William Atkins
ProfessorMedicinal ChemistryPhone: 206-685-0379Website: Website Website: PubMed Articles


Sid Nelson Endowed Professor of Medicinal Chemistry


BS in Chemistry, The College of William and Mary
MA in Pharmacology, Harvard University
PhD in Biochemistry, The University of Illinois
Postdoctoral Studies in Protein Dynamics, Penn State University

Research Interests

  • Structure-function mechanism of glutathione S-transferases and cytochrome P450
  • Protein engineering of supramolecular aggregates


Dr. Atkins is a biophysical enzymologist with two primary areas of interest. One area of research focus includes mechanisms of detoxication enzymes and transporters, which play critical roles in drug metabolism, drug-drug interactions, and interindividual responses to drugs. These enzymes are a fascinating variation on “traditional” enzymes because they have no defined substrates but instead have evolved to recognize a broad range of structurally diverse substrates. Atkins utilizes a combination of spectroscopic methods, mass spectrometry, chemical synthesis, computational methods, and molecular biology techniques to study the structure-function relationships of these enzymes, including Cytochrome P450s (CYPs), glutathione s-transferases (GSTs), and P-glycoprotein (P-gp).

The second area of interest includes therapeutic proteins, such as those used to treat various cancers and autoimmune diseases. The Atkins lab has recently moved into this research field and studies biophysical properties of antibody-drug conjugates and fusion proteins to understand the factors that determine their stability in serum and their interactions with their targets. Taken together, the research projects in the Atkins lab aim to improve the utility of small molecule drugs or biologics.

This research prepares students and postdoctoral scientists for careers in the pharmaceutical industry, the biotechnology sector and academia.

  • Zhao C, Gao Q, Roberts AG, Shaffer SA, Doneanu CE, Xue S, Goodlett DR, Nelson SD, Atkins SM. Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b(5). Biochemistry 51(47):9488-500; ePub Nov 14 (2012).
  • Conner KP, Vennam P, Woods CM, Krzyaniak MD, Bowman MK, Atkins WM. 1,2,3-Triazole-heme interactions in cytochrome P450: functionally competent triazole-water-heme complexes. Biochemistry 51(32):6441-57. ePub Jul 31 (2012).
  • Acchione M, Kwon H, Jochheim CM, Atkins WM. Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates. MAbs 4(3); epub Apri 26 (2012). PubMed link.
  • Ritchie TK, Kwon HW, Atkins WM. Conformational Analysis of Human ATP-Binding Cassette Transporter ABCB1 in Lipid Nanodiscs and Inhibition by the Antibodies MRK16 and UIC2. J Biol Chem, 286(45):39489-96 (2011). PubMed link.
  • Balogh LM, Atkins WM. Interactions of glutathione transferases with 4-hydroxynonenal. Drug Metab Rev. 43(2):165-78 (2011).
  • Honaker MT, Acchione M, Sumida JP, Atkins WM. Ensemble Perspective for Catalytic Promiscuity: Calorimetric Analysis of the Active Site Conformational Landscape of a Detoxification Enzyme. J Biol Chem. 286(49):42770-6 (Dec 9, 2011). PubMed link.
  • Conner KP, Woods CM, Atkins WM. Interactions of cytochrome P450s with their ligands. Arch Biochem Biophys.507(1):56-65 (2011).
  • Atkins WM, Qian H. Stochastic Ensembles, Conformationally Adaptive Teamwork, and Enzymatic Detoxification.Biochemistry, 50(19):3866-72 (2011). PubMed link.
  • Foti RS, Honaker M, Nath A, Pearson JT, Buttrick B, Isoherranen N, Atkins WM. Catalytic versus Inhibitory Promiscuity in Cytochrome P450s: Implications for Evolution of New Function. Biochemstry (New Concepts). 50:2387-2393 (2011).
  • Yang J, Atkins WM, Isoherranen N, Paine MF, Thummel KE. Evidence of CYP3A Allosterism in Vivo: Analysis of Interaction Between Fluconazole and Midazolam. Clin Pharmacol Ther., 91(3):442-9 (2011). PubMed link.
  • Woods CM, Fernandez C, Kunze KL, Atkins WM. Allosteric activation of cytochrome P450 3A4 by α-naphthoflavone: branch point regulation revealed by isotope dilution analysis. Biochemistry. 50(46):10041-51 (Nov 22 2011). PubMed link.
  • Kim J, Park HC, Gedi V, Park HY, Roberts AG, Atkins WM, Yoon MY. Yeast-Hybrid Based High-Throughput Assay for Identification of Anthrax Lethal Factor Inhibitors. Biochem Biophys Res Commun. (2010 Dec 6) Epub ahead of print.
  • Nath A, Zientek MA, Burke BJ, Jiang Y, Atkins WM. Quantifying and Predicting the Promiscuity and Isoform Specificity of Small-Molecule Cytochrome P450 Inhibitors. Drug Metab Dispos. 38(12):2195-203 (2010 Dec) Epub 2010 Sep 14.
  • Shireman LM, Kripps KA, Balogh LM, Conner KP, Whittington D, Atkins WM. Glutathione Transferase A4-4 Resists Adduction by 4-Hydroxynonenal. Arch Biochem Biophys. 504(2):182-9 (2010 Dec 15) Epub 2010 Sep 15.
  • Roberts AG, Cheesman MJ, Primak A, Bowman MK, Atkins WM, Rettie AE. Intramolecular Heme Ligation of the Cytochrome P450 2C9 R108H Mutant Demonstrates Pronounced Conformational Flexibility of the B-C Loop Region: Implications for Substrate Binding. Biochemistry. 49(40):8700-8708 (2010 Oct 12) Epub 2010 Sep 21.
  • Dabrowski MJ, Zolnerciks JK, Balogh LM, Greene RJ, Kavanagh TJ, Atkins WM. Stereoselective Effects of 4-Hydroxynonenal in Cultured Mouse Hepatocytes. Chemical Res Toxicol. (2010 Sep 28) Epub ahead of print.

Nicolas Au Graduate Student

No Photo Available

David Baggett Graduate Student

No Photo Available

Thomas Baillie Professor, Dean Emeritus

Photo of Thomas Baillie
Professor, Dean EmeritusMedicinal Chemistry


PhD in organic chemistry, DSc in chemistry, University of Glasgow;
MSc in biochemistry, University of London;
BSc in chemistry, University of Glasgow

Research Interests

  • Application of mass spectrometry and associated techniques to problems in pharmacology, toxicology and clinical research
  • Mechanistic aspects of drug metabolism and toxicology


Dr. Baillie’s academic career began at the University of London, in 1975, where he was a lecturer in the Department of Clinical Pharmacology. In 1978, he joined the University of California – San Francisco and, in 1981, he became a member of the UW Department of Medicinal Chemistry faculty, where he stayed until joining Merck & Co. in 1994. At Merck, he served as executive director of preclinical drug metabolism, and subsequently as vice president and global head of drug metabolism and pharmacokinetics. He returned to the UW School of Pharmacy as dean in 2008.

Baillie’s research has focused on how the body forms and processes chemically reactive, potentially harmful products during the process of drug metabolism. These findings are important in guiding the design of safer medicines. Baillie was awarded a Senior International Fogarty Fellowship (1988-89) for research conducted at the Karolinska Institute in Stockholm, Sweden. He is author of more than 250 publications, serves on the advisory boards of several scientific journals and professional organizations and, in 2002, he was a co-recipient of the James R. Gillette Award from the American Society of Pharmacology & Experimental Therapeutics. In 2009, he received a Lifetime Achievement Award from the International Isotope Society for distinguished service to the society. In 2012, he received the Founders Award from the American Chemical Society Division of Chemical Toxicology. He has been elected as a Fellow of the Royal Society of Chemistry, the Japanese Society for the Study of Xenobiotics, and the American Chemical Society.

Preeti Bajaj Graduate Student

Photo of Preeti Bajaj
Graduate StudentDepartment of Pharmacy

Admission: Fall 2009
BS, Biomedical Engineering, Johns Hopkins University

Research Interests: Pharmacoeconomics and outcomes research locally and in resource poor countries, informed decision-making and efficiency in drug and medical device development

Souvik Banerjee Post-Doctoral Pfizer Fellow

Photo of Souvik Banerjee
Post-Doctoral Pfizer FellowPORPPDepartment of Pharmacy

Pfizer Fellow 2014-2016

Souvik joined the Pfizer postdoctoral fellowship after completing his PhD in Economics from University at Albany, SUNY in August 2014. In his dissertation he examined the impact of mental illness on labor market outcomes like employment and labor supply, using a latent continuous measure for mental illness. Souvik has presented his work at the Ifo/CESifo Conference on Empirical Health Economics, Munich, Germany and also at the Annual Health Econometrics Workshop, Chapel Hill, NC in 2013.

In the position as a postdoctoral fellow he will be working under the primary supervision of Lou Garrison and will also be mentored by Sean D. Sullivan and Anirban Basu. In the summer of 2015 Souvik is expected to work with Dick Willke at Pfizer, New York, NY.

Aasthaa Bansal Research Assistant Professor

Photo of Aasthaa Bansal
Research Assistant ProfessorDepartment of PharmacyAddress 1959 NE Pacific St375-B 375-B Phone: 206.685.9658

Research Assistant Professor, Department of Pharmacy

PhD in Biostatistics, University of Washington
BMath in Computer Science, University of Waterloo, Canada

Research Interests

  • Biostatistics

Aasthaa Bansal received her PhD in biostatistics from the UW and completed her postdoctoral fellowship at the UW. Prior to arriving in Seattle, she received a BMath in Computer Science from the University of Waterloo, Canada.

Her research interests include the statistical evaluation of biomarkers and medical tests for disease prognosis and treatment selection. In addition to her background developing statistical methodology, she was involved in collaborative research at the Center for Biomedical Statistics from 2009 to 2013. While there, she worked with academic investigators on the statistical analysis of studies in colon cancer screening, esophageal cancer treatment, institutional profiling, chronic illness management and juvenile arthritis.

Bansal A, Pepe MS. When Does Combining Markers Improve Classification Performance and What Are Implications for Practice?Stat Med.2013 May 20;32(11):1877-92.

Bansal A, Pepe MS. Estimating Improvement in Prediction with Matched Case-Control Designs.Lifetime Data Anal.2013 Apr;19(2):170-201.

Kerr KF,Bansal A, Pepe MS.Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context.Am J Epidemiol.2012 Sep 15;176(6):482-7. Epub 2012 Aug 8.

Larson-Meyer DE, Palm S,Bansal A, Austin KJ, Hart AM, Alexander BM. Influence of Running and Walking on Hormonal Regulators of Appetite in Women.J Obes.2012;2012:730409.

Weinert C, Cudney S, Comstock B,Bansal A. Computer Intervention Impact on Psychosocial Adaptation of Rural Women with Chronic Conditions.Nurs Res.2011 Mar-Apr;60(2):82-91.

Adams Waldorf KM, Gravett MG, McAdams RM, Paolella LJ, Gough GM, Carl DJ,Bansal A, Liggitt HD, Kapur RP, Reitz FB, Rubens CE. Choriodecidual Group B Streptococcal Inoculation Induces Fetal Lung Injury without Intra-Amniotic Infection and Preterm Labor inMacaca Nemestrina.PLoS One.2011;6(12):e28972.

Larry Bauer Professor

No Photo Available
ProfessorDepartment of PharmacyAddress H375T Box 357630 1959 NE Pacific St Seattle WA 98195-7630 Phone: 206.685.2713 Work Fax: 206.543.3835

Professor, Department of Pharmacy; Adjunct Professor, Department of Laboratory Medicine, UW Medicine

PharmD, University of Kentucky; Bachelor of Science in Pharmacy, University of Washington

Research Interests

  • Drug interactions
  • Individualization of drug therapy

Courses Taught

  • Pharmacy 560: Therapeutics II
  • Pharmacy 566: Applied Kinetics
  • Pharmacy 559: Therapeutics I
  • Pharmacy 301: Medications & Health

Dr. Bauer is a member of several clinical pharmacology and clinical pharmacy professional organizations. He is a reviewer for several scientific publications, was Consulting Editor of Clinical Pharmacy (1981 – 1990), Field Editor of ASHP Signal (1981 – 1983), and on the Editorial Board of Clinical Pharmacology and Therapeutics (1998-2007).

Currently, he is on the Editorial Board of Antimicrobial Agents and Chemotherapy. He is a Fellow in the American College of Clinical Pharmacology and in the American College of Clinical Pharmacy. Dr. Bauer has precepted post-doctoral fellows in clinical pharmacokinetics and pharmacodynamics who currently have faculty appointments in schools of pharmacy or are employed in pharmaceutical industry. He is the author of Applied Clinical Pharmacokinetics and Clinical Pharmacokinetics Handbook.

Hannah Baughman Graduate Student

No Photo Available

Meagan Bemer Research Scientist

No Photo Available
Research ScientistDepartment of Pharmaceutics

Mark Benhaim Graduate Student

No Photo Available

Caroline Bennette Graduate Student

Photo of Caroline Bennette
Graduate StudentDepartment of Pharmacy

Admission: Fall 20011
BS, Biomedical Engineering, Johns Hopkins University

Research Interests: Pharmacoeconomics and outcomes research locally and in resource poor countries, informed decision-making and efficiency in drug and medical device development

Douglas Black Associate Professor

Photo of Douglas Black
Associate ProfessorDepartment of PharmacyAddress H375-U Seattle WA 98195-7630 Phone: 206.685.2714 Work Fax: 206.543.3835

Associate Professor, Department of Pharmacy

PharmD, Bachelor of Science in Pharmacy, University of Washington
Research Interests

  • Antiobiotic resistance
  • Surveillance mechanisms

Courses Taught

  • Pharm 519: Pharmacotherapeutics for Infectious Disease & Infection
  • Pharm 559: Pharmacotherapeutics II

Dr. Black has been a faculty member in the Department of Pharmacy since 1989. He precepts pharmacy students and pharmacy residents in his role as a clinical staff pharmacist at the UW Medical Center’s Division of Infectious Diseases. Previously, he was a clinical staff pharmacist in oncology at UW Medical Center, working on medications for cancer patients. He also has taught pharmacology for nursing students at Seattle Pacific University.

In addition to teaching in the PharmD curriculum, Black teaches a class in medications for master’s-level nursing students, and he gives numerous guest lectures each quarter on treatment for infectious diseases, focusing on antibiotics. He has also taught numerous elective courses in pharmacy and a class for physician assistant students in the Medex program (the UW Physician Assistant degree program). In 2007, he received the UW’s Distinguished Teaching Award. In 2011, a group of pharmacy students and alumni raised the funds to create the Doug Black PharmD Endowed Award — a yearly scholarship which goes to a student who exemplifies Doug’s enthusiastic perspective on education.

Black has served as contributing editor for “The Sanford Guide to Antimicrobial Therapy” since 2010.


Comments are closed.